B A S E C A R E
Clinical Research Innovation Base Co-developed by Guangdong Provincial Fertility Hospital and Basecare Medical
September 17, 2021 · Suzhou
The strategic cooperation seminar cohosted by Guangdong Provincial Fertility Hospital and Basecare medical was successfully held in Guangdong Provincial Fertility Hospital on September 16, 2021.

The strategic cooperation seminar cohosted by Guangdong Provincial Fertility Hospital and Basecare medical was successfully held in Guangdong Provincial Fertility Hospital on September 16, 2021.Li Guanming,president and party secretary of Guangdong Provincial Fertility Hospital, Zhao Qingguo and Huang Weibiao, vice president of Guangdong Provincial Fertility Hospital, Liangbo, Chairman of the board of Basecare, Kong Linyin, technical director of Basecare, Du Renqian,lead researcher of Basecare attended the meeting. The two parties reached a cooperative agreement on “Cohort study of gene mutation frequency” and unveiled a plaque for the jointly developed Clinical Research Innovation Base.


Li Guanming, president and party secretary of Guangdong Provincial Fertility Hospital delivered a welcome speech. As a reproductive hospital specialized in the field of reproduction, Guangdong Provincial Fertility Hospital owns the only key laboratory of male reproduction and genetics approved by the National Health commission and Guangdong Human Sperm Bank. It’s also one of the three Human Sperm Bank training base of the National Health Commision with self-sperm reserve rank first in China. This cooperation will help to realize the genetic level matching between sperm donor and receiver to ensure the genetic security of the following generation. Meanwhile, the establishment of Clinical Research Innovation Base will provide soft power support for the scientific research development of hospitals, help improve the scientific research utilization efficiency of clinical samples and promote the quick transformation of sample resources into research results to further facilitate the development of the hospital into a high level research reproductive institute, the president said.

Liangbo, Chairman of the board of Basecare expressed his gratitude to Guangdong Provincial Fertility Hospital for providing the opportunity and platform for cooperation. As the first IVD listed company of assisted reproduction, Basecare has been devoted to the R&D and application of genetic technology in the field of assisted reproduction. In combination with the R&D and industrial advantages of Basecare, the cooperation can fully explore the advantages of samples resources and research of Guangdong Human Sperm Bank, which will have obvious promotion and improvement effect on both the domestic clinical innovation research impact of Guangdong Human Sperm Bank and the industry influence of Basecare in the field of reproductive health. Rely on the large-scale industrialization base, Basecare will provide R&D personnel and technical support for the Clinical Research Innovation Base with the aim of accelerating the industrialization transformation of technology and promoting the development of sperm bank technology to realize the extensive application of technology.


The cooperation actively promotes the integration of medical research institutions and leading enterprises in the industry to responded to the national call of “Healthy China2030”In the future, the two parties will build an overall solution from the automatic sperm detection to automatic sperm storage in the Clinical Research Innovation Base, further strengthen the strategy cooperation in andrology based on sperm genetics and make contributions to the eugenics work of Guangdong province and even the whole China.